Table 6.
WHO 2016 Classification of CNS Tumours Diffuse astrocytic and oligodendroglial tumours |
WHO 2021 Classification of CNS Tumours Gliomas, glioneuronal tumours and neuronal tumours Adult-type diffuse gliomas |
---|---|
Diffuse astrocytoma, IDH-mutant, WHO grade II | Astrocytoma, IDH-mutant, CNS WHO grade 2 |
Anaplastic astrocytoma, IDH-mutant, WHO grade III | Astrocytoma, IDH-mutant, CNS WHO grade 3 |
Glioblastoma, IDH-mutant WHO grade IV (secondary glioblastoma) | Astrocytoma, IDH-mutant, CNS WHO grade 4 |
Diffuse astrocytoma, IDH-wildtype, WHO grade II* | Glioblastoma, IDH-wildtype, CNS WHO grade 4 |
Anaplastic astrocytoma, IDH-wildtype, WHO grade III* | |
Glioblastoma, IDH-wildtype, WHO grade IV (primary glioblastoma) | |
Oligodendroglioma, IDH-mutant and 1p/19q codeleted, WHO grade II | Oligodendroglioma, IDH-mutant and 1p/19q codeleted, CNS WHO grade 2 |
Anaplastic oligodendroglioma, IDH-mutant and 1p/19q codeleted WHO grade III | Oligodendroglioma, IDH-mutant and 1p/19q codeleted, CNS WHO grade 3 |
*Detection of TERTp mutation, EGFR amplification, and/or +7/−10 (Table inspired by [42])